Dr Reddys Lab gets USFDA nod; stock trades firms

Written By Unknown on Kamis, 08 November 2012 | 12.44

Dr Reddys Laboratories gets USFDA nod for its generic palonosetron hydrochloride injection, reports DNA.

At 09:36 hrs Dr Reddys Laboratories was quoting at Rs 1,798, up Rs 3.85, or 0.21%. It has touched an intraday high of Rs 1,803 and an intraday low of Rs 1,782.
 
It was trading with volumes of 2,214 shares. In the previous trading session, the share closed up 0.46% or Rs 8.25 at Rs 1,794.15.

The company's trailing 12-month (TTM) EPS was at Rs 51.10 per share. (Sep, 2012). The stock's price-to-earnings (P/E) ratio was 35.19. The latest book value of the company is Rs 395.56 per share. At current value, the price-to-book value of the company was 4.55. The dividend yield of the company was 0.76%.



Anda sedang membaca artikel tentang

Dr Reddys Lab gets USFDA nod; stock trades firms

Dengan url

https://olahragakecantikan.blogspot.com/2012/11/dr-reddys-lab-gets-usfda-nod-stock.html

Anda boleh menyebar luaskannya atau mengcopy paste-nya

Dr Reddys Lab gets USFDA nod; stock trades firms

namun jangan lupa untuk meletakkan link

Dr Reddys Lab gets USFDA nod; stock trades firms

sebagai sumbernya

0 komentar:

Posting Komentar

techieblogger.com Techie Blogger Techie Blogger